{"id":"pritor","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute pancreatitis","Anuria","Azotemia","Cholestasis","Chronic idiopathic constipation","Dehydration","Diabetes mellitus","Disease of liver","Gout","Hepatic coma","Hepatic failure","Hypercalcemia","Hypercholesterolemia","Hyperkalemia","Hyperparathyroidism","Hyperuricemia","Hypochloremic alkalosis","Hypokalemia","Hypomagnesemia","Hyponatremia","Hypovolemia","Kidney disease","Low blood pressure","Neonatal hyperbilirubinemia","Obstruction of bile duct","Pregnancy, function","Renal artery stenosis","Second trimester pregnancy","Secondary angle-closure glaucoma","Severe Aortic Valve Stenosis","Severe hepatic impairment","Severe renal impairment","Sympathectomy","Systemic lupus erythematosus","Third trimester pregnancy"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"ATP-binding cassette sub-family G member 2, Multidrug and toxin extrusion protein 1, Type-2 angiotensin II receptor"},"_scrapedAt":"2026-03-28T05:22:23.476Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Cerebrovascular accident","diseaseId":"cerebrovascular-accident","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Disorder due to type 2 diabetes mellitus","diseaseId":"disorder-due-to-type-2-diabetes-mellitus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"History of myocardial infarction due to atherothrombotic coronary artery disease","diseaseId":"history-of-myocardial-infarction-due-to-atherothrombotic-coronary-artery-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypertensive disorder","diseaseId":"hypertensive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Myocardial Infarction Prevention","diseaseId":"myocardial-infarction-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06041529","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yuhan Corporation","startDate":"2023-10-18","conditions":"Essential Hypertension","enrollment":198},{"nctId":"NCT07370506","phase":"PHASE1, PHASE2","title":"Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02","conditions":"Breast Cancer, Doxorubicin Induced Cardiomyopathy","enrollment":36},{"nctId":"NCT06815497","phase":"PHASE2","title":"Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer","status":"RECRUITING","sponsor":"Tyler J Curiel","startDate":"2026-01-21","conditions":"Ovarian Cancer","enrollment":33},{"nctId":"NCT06483789","phase":"PHASE2","title":"Efficacy and Safety of HB-1 for Panic Disorder","status":"RECRUITING","sponsor":"Honeybrains Biotech LLC","startDate":"2024-10-29","conditions":"Panic Disorder, Mental Illness","enrollment":240},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT07030101","phase":"PHASE3","title":"A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension","status":"NOT_YET_RECRUITING","sponsor":"EMS","startDate":"2026-11","conditions":"Hypertension","enrollment":400},{"nctId":"NCT07207057","phase":"PHASE3","title":"Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial","status":"RECRUITING","sponsor":"University College, London","startDate":"2025-09-12","conditions":"Parkinsons Disease (PD)","enrollment":1200},{"nctId":"NCT06647745","phase":"PHASE3","title":"A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension","status":"RECRUITING","sponsor":"THPharm Corp.","startDate":"2025-04-10","conditions":"Type 2 Diabetes, Hypertension","enrollment":221},{"nctId":"NCT02699645","phase":"PHASE3","title":"Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-09-28","conditions":"Intracerebral Haemorrhage (ICH), Hypertension","enrollment":1671},{"nctId":"NCT06168487","phase":"PHASE1","title":"Telmisartan in Prostate Cancer","status":"RECRUITING","sponsor":"Tyler J Curiel","startDate":"2024-04-22","conditions":"Prostate Cancer","enrollment":36},{"nctId":"NCT02373163","phase":"PHASE4","title":"INTERVENCION Trial","status":"COMPLETED","sponsor":"Prevencion","startDate":"2014-09-01","conditions":"Blood Pressure, High","enrollment":166},{"nctId":"NCT04518293","phase":"PHASE3","title":"Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension","status":"COMPLETED","sponsor":"George Medicines PTY Limited","startDate":"2021-07-09","conditions":"Hypertension","enrollment":1385},{"nctId":"NCT04518306","phase":"PHASE3","title":"Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension","status":"COMPLETED","sponsor":"George Medicines PTY Limited","startDate":"2021-06-14","conditions":"Hypertension","enrollment":755},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT02085265","phase":"PHASE2","title":"Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients","status":"TERMINATED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2014-03","conditions":"Alzheimer's Disease","enrollment":23},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT00274105","phase":"PHASE4","title":"SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2001-03-01","conditions":"Hypertension, Coronary Arteriosclerosis","enrollment":22},{"nctId":"NCT04466241","phase":"PHASE2, PHASE3","title":"Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2020-11-27","conditions":"COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":294},{"nctId":"NCT06282549","phase":"","title":"Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yuhan Corporation","startDate":"2022-06-08","conditions":"Essential Hypertension","enrollment":1219},{"nctId":"NCT02620163","phase":"PHASE3","title":"Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2015-12","conditions":"Hypertension","enrollment":381},{"nctId":"NCT03662620","phase":"PHASE1","title":"Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-10-05","conditions":"Hypertension","enrollment":67},{"nctId":"NCT05322889","phase":"PHASE2","title":"Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel)","status":"COMPLETED","sponsor":"Dr. Frank Behrens","startDate":"2020-04-09","conditions":"Neuropathic Pain, Chemotherapy Effect","enrollment":35},{"nctId":"NCT06515652","phase":"NA","title":"To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome","status":"RECRUITING","sponsor":"Hamdard University","startDate":"2023-09-01","conditions":"Metabolic Syndrome","enrollment":200},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06431477","phase":"PHASE4","title":"Efficacy and Safety of Telmisartan Compared With Losartan","status":"RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-04-19","conditions":"Diabetic Nephropathies, Hypertension","enrollment":98},{"nctId":"NCT02471833","phase":"PHASE1, PHASE2","title":"Health Evaluation in African Americans Using RAS Therapy","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-04","conditions":"Alzheimer's Disease","enrollment":61},{"nctId":"NCT02338232","phase":"NA","title":"Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation","status":"TERMINATED","sponsor":"Hackensack Meridian Health","startDate":"2015-07-07","conditions":"GVHD","enrollment":32},{"nctId":"NCT06214832","phase":"","title":"An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)","status":"UNKNOWN","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2021-11-11","conditions":"Hypertension","enrollment":4000},{"nctId":"NCT00242814","phase":"PHASE4","title":"Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2005-11-03","conditions":"Hypertension, Metabolic Syndrome X","enrollment":100},{"nctId":"NCT02262780","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-12-01","conditions":"Healthy","enrollment":20},{"nctId":"NCT00168857","phase":"PHASE4","title":"A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-07-09","conditions":"Hypertension, Diabetic Nephropathies","enrollment":860},{"nctId":"NCT00274599","phase":"PHASE4","title":"PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2002-10-09","conditions":"Hypertension","enrollment":812},{"nctId":"NCT06063109","phase":"PHASE1","title":"A Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of Telmisartan and Dapagliflozin.","status":"COMPLETED","sponsor":"THPharm Corp.","startDate":"2023-10-09","conditions":"Hypertension, Diabetes Mellitus, Type 2","enrollment":51},{"nctId":"NCT04510662","phase":"PHASE2","title":"Telmisartan in Respiratory Failure Due to COVID-19","status":"COMPLETED","sponsor":"Abraham Edgar Gracia-Ramos","startDate":"2020-08-12","conditions":"COVID-19, Respiratory Insufficiency, Telmisartan","enrollment":66},{"nctId":"NCT04970108","phase":"PHASE3","title":"Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension","status":"WITHDRAWN","sponsor":"EMS","startDate":"2023-08","conditions":"Hypertension Associated, Type II Diabetes Mellitus","enrollment":""},{"nctId":"NCT05144360","phase":"PHASE3","title":"Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension","status":"WITHDRAWN","sponsor":"EMS","startDate":"2022-08","conditions":"Hypertension Associated, Type II Diabetes Mellitus","enrollment":""},{"nctId":"NCT04360551","phase":"PHASE2","title":"Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients","status":"TERMINATED","sponsor":"University of Hawaii","startDate":"2020-07-01","conditions":"COVID-19","enrollment":24},{"nctId":"NCT04354350","phase":"","title":"Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-09-22","conditions":"Hypertension","enrollment":63744},{"nctId":"NCT04354376","phase":"","title":"Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-09-22","conditions":"Hypertension","enrollment":40048},{"nctId":"NCT05155436","phase":"PHASE4","title":"Occurrence of Dyskalemia With Treatment for Hypertension","status":"COMPLETED","sponsor":"National Heart Foundation of Bangladesh","startDate":"2022-01-15","conditions":"Hypertension, Potassium Imbalance","enrollment":1090},{"nctId":"NCT04736329","phase":"NA","title":"Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-02-01","conditions":"Heart Failure With Reduced Ejection Fraction, Renal Insufficiency","enrollment":107},{"nctId":"NCT04021550","phase":"EARLY_PHASE1","title":"Improving 24-hour Blood Pressure in Obstructive Sleep Apnea","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2023-05","conditions":"Obstructive Sleep Apnea","enrollment":""},{"nctId":"NCT05843162","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-06-01","conditions":"Essential Hypertension, Metabolic Syndrome","enrollment":116},{"nctId":"NCT04606563","phase":"PHASE3","title":"Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?","status":"TERMINATED","sponsor":"University of British Columbia","startDate":"2020-10-09","conditions":"Covid19, SARS-CoV Infection","enrollment":341},{"nctId":"NCT04920838","phase":"PHASE2, PHASE3","title":"Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection","status":"UNKNOWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2021-04-12","conditions":"Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":600},{"nctId":"NCT02593110","phase":"NA","title":"Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-01-04","conditions":"Peripheral Artery Disease","enrollment":114},{"nctId":"NCT04359953","phase":"PHASE3","title":"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-04-25","conditions":"COVID-19 Infection","enrollment":16},{"nctId":"NCT04715763","phase":"PHASE2","title":"INvestigating TELmisartin Study","status":"TERMINATED","sponsor":"University of Hawaii","startDate":"2021-09-01","conditions":"Covid19","enrollment":24},{"nctId":"NCT03205137","phase":"","title":"Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice","status":"WITHDRAWN","sponsor":"Boehringer Ingelheim","startDate":"2022-06-01","conditions":"Hypertension","enrollment":""},{"nctId":"NCT02768948","phase":"NA","title":"Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2017-05-05","conditions":"Diabetic Nephropathy","enrollment":20},{"nctId":"NCT05328310","phase":"NA","title":"Effect of Different Antihypertensive Drugs on Central Blood Pressure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2019-01-06","conditions":"Hypertension","enrollment":110},{"nctId":"NCT04394117","phase":"PHASE4","title":"Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease","status":"COMPLETED","sponsor":"The George Institute","startDate":"2020-06-19","conditions":"Coronavirus Disease 2019, COVID-19","enrollment":787},{"nctId":"NCT03868839","phase":"PHASE2","title":"Telmisartan Pilot Study on Treatment Resistant Schizophrenia","status":"TERMINATED","sponsor":"Xiaoduo Fan","startDate":"2019-02-01","conditions":"Schizophrenia, Schizo Affective Disorder, Treatment-resistant Schizophrenia","enrollment":6},{"nctId":"NCT05223101","phase":"PHASE1","title":"A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers","status":"UNKNOWN","sponsor":"HK inno.N Corporation","startDate":"2022-01-19","conditions":"Hypertension","enrollment":46},{"nctId":"NCT05040880","phase":"PHASE1","title":"A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2021-07-08","conditions":"Hypertension","enrollment":46},{"nctId":"NCT04356495","phase":"PHASE2, PHASE3","title":"Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2020-07-29","conditions":"Corona Virus Infection, Sars-CoV2","enrollment":412},{"nctId":"NCT01928927","phase":"PHASE2","title":"Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study)","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2014-01","conditions":"HIV-1 Infection","enrollment":58},{"nctId":"NCT04218552","phase":"PHASE2","title":"Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2020-02-25","conditions":"Hypertension,Essential","enrollment":176},{"nctId":"NCT03474562","phase":"PHASE4","title":"High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-04-03","conditions":"ASCVD, Impaired Fasting Glucose, Hypertension","enrollment":100},{"nctId":"NCT03783754","phase":"NA","title":"Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study","status":"TERMINATED","sponsor":"The George Institute","startDate":"2018-08-09","conditions":"Stroke, Cerebral Small Vessel Diseases, Intracerebral Hemorrhage","enrollment":4},{"nctId":"NCT04158076","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2020-01-23","conditions":"Hypercholesterolemia, Hypertension","enrollment":131},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03267329","phase":"PHASE4","title":"Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-09-11","conditions":"Hypertension, Dyslipidemia","enrollment":80},{"nctId":"NCT03785067","phase":"PHASE3","title":"Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study","status":"TERMINATED","sponsor":"The George Institute","startDate":"2020-02-27","conditions":"Cognitive Decline, Intracerebral Hemorrhage, Dementia, Vascular","enrollment":1},{"nctId":"NCT04743063","phase":"","title":"Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2021-01-14","conditions":"Heart Failure, Systolic, Frailty","enrollment":40000},{"nctId":"NCT03319823","phase":"PHASE4","title":"Treating Nocturnal Hypertension and Nocturia in African American Men","status":"WITHDRAWN","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-10-25","conditions":"High Blood Pressure","enrollment":""},{"nctId":"NCT00421863","phase":"PHASE4","title":"Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study","status":"COMPLETED","sponsor":"Heart Care Foundation","startDate":"2005-02","conditions":"Hypertension","enrollment":1111},{"nctId":"NCT03872232","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2019-02-26","conditions":"Hypercholesterolemia, Hypertension","enrollment":180},{"nctId":"NCT04355936","phase":"PHASE4","title":"Telmisartan for Treatment of COVID-19 Patients","status":"COMPLETED","sponsor":"Laboratorio Elea Phoenix S.A.","startDate":"2020-05-19","conditions":"COVID-19 Drug Treatment","enrollment":400},{"nctId":"NCT04667624","phase":"PHASE1","title":"Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2020-02-29","conditions":"Hypertension","enrollment":32},{"nctId":"NCT03550859","phase":"PHASE4","title":"HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria","status":"UNKNOWN","sponsor":"Yuhan Corporation","startDate":"2018-06-05","conditions":"Chronic Kidney Disease, Proteinuria","enrollment":374},{"nctId":"NCT04659070","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia","status":"UNKNOWN","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2020-07-15","conditions":"Primary Hypercholesterolemia, Hypertension","enrollment":156},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04436419","phase":"NA","title":"Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study","status":"COMPLETED","sponsor":"Fauqué","startDate":"2018-07-02","conditions":"Obesity, Obesity, Abdominal, Obesity, Visceral","enrollment":40},{"nctId":"NCT01683084","phase":"PHASE4","title":"Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms","status":"COMPLETED","sponsor":"Palo Alto Veterans Institute for Research","startDate":"2012-09-19","conditions":"Abdominal Aortic Aneurysm","enrollment":22},{"nctId":"NCT03021265","phase":"","title":"To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-01-20","conditions":"Hypertension","enrollment":676},{"nctId":"NCT01885559","phase":"PHASE3","title":"HALT Progression of Polycystic Kidney Disease Study B","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-01","conditions":"Kidney, Polycystic","enrollment":486},{"nctId":"NCT00283686","phase":"PHASE3","title":"HALT Progression of Polycystic Kidney Disease Study A","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-01","conditions":"Kidney, Polycystic","enrollment":558},{"nctId":"NCT00185705","phase":"NA","title":"Treatment of Insulin Resistance in Hypertensive, Obese Adolescents","status":"TERMINATED","sponsor":"Stanford University","startDate":"2006-10","conditions":"Hypertension, Insulin Resistance, Dyslipidemia","enrollment":30},{"nctId":"NCT02170246","phase":"PHASE1","title":"Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-01-28","conditions":"Acute HIV Infection, HIV Infections","enrollment":21},{"nctId":"NCT02231788","phase":"PHASE4","title":"The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2014-06","conditions":"Hypertension","enrollment":217},{"nctId":"NCT00946829","phase":"","title":"Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-01","conditions":"Hypertension","enrollment":18299},{"nctId":"NCT02750059","phase":"PHASE2","title":"Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis","status":"COMPLETED","sponsor":"SEARCH Research Foundation","startDate":"2015-01","conditions":"Acute HIV Infection, HIV CNS Involvement","enrollment":21},{"nctId":"NCT01202721","phase":"PHASE3","title":"Beta Blockers and Angiotensin Receptor Blockers in Bicuspid Aortic Valve Disease Aortopathy (BAV Study)","status":"TERMINATED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2011-06","conditions":"Cardiac Disease","enrollment":85},{"nctId":"NCT03707899","phase":"PHASE1","title":"The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2018-12-13","conditions":"Hypertension With Dyslipidemia","enrollment":49},{"nctId":"NCT04061824","phase":"PHASE4","title":"Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2016-05-24","conditions":"Hypertension, Dyslipidemias","enrollment":150},{"nctId":"NCT03956823","phase":"NA","title":"Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With Hypertension","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2019-08-01","conditions":"Hypertension","enrollment":300},{"nctId":"NCT02968160","phase":"PHASE4","title":"A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome","status":"TERMINATED","sponsor":"Yuhan Corporation","startDate":"2016-10","conditions":"Metabolic Syndrome","enrollment":55},{"nctId":"NCT03889145","phase":"PHASE1","title":"A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide","status":"COMPLETED","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2013-12-19","conditions":"Healthy","enrollment":30},{"nctId":"NCT03006341","phase":"","title":"Validation of Predictors of OAC Initiation Using EMR Data","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-02-28","conditions":"Atrial Fibrillation","enrollment":140187},{"nctId":"NCT03860220","phase":"PHASE4","title":"The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin","status":"UNKNOWN","sponsor":"Hyo-Soo Kim","startDate":"2019-03-01","conditions":"Hypertension, Dyslipidemias","enrollment":304},{"nctId":"NCT01088295","phase":"PHASE2","title":"HIV and Fat Accumulation","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2010-05","conditions":"HIV Infection","enrollment":35},{"nctId":"NCT03143166","phase":"PHASE1","title":"Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-05-22","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":36},{"nctId":"NCT03116516","phase":"PHASE1","title":"Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-04-21","conditions":"Hypertension, Hyperlipidemia","enrollment":62},{"nctId":"NCT03067688","phase":"PHASE3","title":"Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-04-11","conditions":"Hypertension, Hyperlipidemia","enrollment":202},{"nctId":"NCT03705533","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2018-09-07","conditions":"Bioequivalence","enrollment":26},{"nctId":"NCT01271478","phase":"PHASE4","title":"Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients","status":"COMPLETED","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2009-08","conditions":"Inflammation, End-stage Renal Disease","enrollment":60},{"nctId":"NCT03742544","phase":"","title":"Post Marketing Surveillance of Telostop TAB (Telmisartan/Rosuvastatin) for Evaluating the Safety and Efficacy","status":"UNKNOWN","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2015-06-23","conditions":"Hypertension, Dyslipidemias","enrollment":600},{"nctId":"NCT01243268","phase":"","title":"A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2010-12-21","conditions":"Hypertension","enrollment":674},{"nctId":"NCT03504566","phase":"PHASE4","title":"Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)","status":"WITHDRAWN","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2017-11-15","conditions":"Diabetic Nephropathy Type 2","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":41,"reaction":"DIARRHOEA"},{"count":40,"reaction":"ASTHENIA"},{"count":31,"reaction":"VOMITING"},{"count":30,"reaction":"DRUG INTERACTION"},{"count":27,"reaction":"ACUTE KIDNEY INJURY"},{"count":26,"reaction":"HYPONATRAEMIA"},{"count":25,"reaction":"MALAISE"},{"count":25,"reaction":"SYNCOPE"},{"count":24,"reaction":"BLOOD PRESSURE INCREASED"},{"count":24,"reaction":"FALL"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Pritor","genericName":"Pritor","companyName":"DongKoo Bio & Pharma","companyId":"dongkoo-bio-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Telmisartan is a medication used to treat high blood pressure and heart failure. It works as a type-1 angiotensin II receptor antagonist, a small molecule that blocks the action of angiotensin II on its receptor.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"approved","approval_date":"1998-12-11T00:00:00.000Z","mah":"Bayer AG","brand_name_local":"Pritor","application_number":"EMEA/H/C/000210"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}